MedPath

Effects of Ipragliflozin on Body Composition in Type 1 Diabetic Patients

Not Applicable
Recruiting
Conditions
type 1 diabetic patients
Registration Number
JPRN-UMIN000036039
Lead Sponsor
Ise Red Cross Hospital Department of Metabolic Diseases
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who had ketoacidosis or coma Malignancies or other diseases with poor prognosis eGFR<60mL/min/1.73m2

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Body Composition
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath